- Part of continuing effort to reduce costs and improve operating
efficiencies
- Approximate ongoing annual cost reduction of more than $1 million
LITTLE FALLS, N.J., June 30 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced that its Minntech Corporation subsidiary will relocate all of its remaining Dutch manufacturing operations to the United States. This action is part of Cantel's continuing effort to reduce operating costs and leverage the existing infrastructure of its Minntech operations in Minneapolis.
The elimination of the Dutch manufacturing operations will lead to the discontinuance of onsite material management, quality assurance, finance and accounting, human resources and some customer service functions. Minntech will continue to maintain a strong marketing, sales, service and technical support presence based in Holland to serve customers throughout Europe, the Middle East and Africa.
According to Andrew Krakauer, Cantel's President, "This action is designed to keep a strong sales and service presence in Europe, while significantly leveraging existing infrastructure and overhead in our Minntech subsidiary. This streamlining should be completed by December 31, 2008 and is anticipated to result in annual pre-tax savings of over $1,000,000."
In connection with the relocation plan, based on management's
preliminary good faith estimate, the Company anticipates incurring
severance costs of approximately $550,000, asset impairment charges in the
range of $200,000 to $300,000 and inventory write-down and other associated
costs of approximately $200,000. Of those amounts, the Company anticipates
that approximately 50-60% will be recorded in the 4th
'/>"/>
| SOURCE Cantel Medical Corp. Copyright©2008 PR Newswire. All rights reserved |